272 related articles for article (PubMed ID: 19996270)
1. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.
Cui J; Wang Q; Wang J; Lv M; Zhu N; Li Y; Feng J; Shen B; Zhang J
Mol Cancer Ther; 2009 Dec; 8(12):3214-22. PubMed ID: 19996270
[TBL] [Abstract][Full Text] [Related]
2. Defective anchoring of JNK1 in the cytoplasm by MKK7 in Jurkat cells is associated with resistance to Fas-mediated apoptosis.
Wang J; Tang R; Lv M; Wang Q; Zhang X; Guo Y; Chang H; Qiao C; Xiao H; Li X; Li Y; Shen B; Zhang J
Mol Biol Cell; 2011 Jan; 22(1):117-27. PubMed ID: 21148294
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest.
Kuntzen C; Sonuc N; De Toni EN; Opelz C; Mucha SR; Gerbes AL; Eichhorst ST
Cancer Res; 2005 Aug; 65(15):6780-8. PubMed ID: 16061660
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
Bose C; Udupa KB
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C394-405. PubMed ID: 18550701
[TBL] [Abstract][Full Text] [Related]
5. Activation of NAG-1 via JNK signaling revealed an isochaihulactone-triggered cell death in human LNCaP prostate cancer cells.
Chiu SC; Wang MJ; Yang HH; Chen SP; Huang SY; Chen YL; Lin SZ; Harn HJ; Pang CY
BMC Cancer; 2011 Apr; 11():146. PubMed ID: 21504622
[TBL] [Abstract][Full Text] [Related]
6. JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis.
Alexaki VI; Javelaud D; Mauviel A
Pigment Cell Melanoma Res; 2008 Aug; 21(4):429-38. PubMed ID: 18541008
[TBL] [Abstract][Full Text] [Related]
7. NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.
Leventaki V; Drakos E; Medeiros LJ; Lim MS; Elenitoba-Johnson KS; Claret FX; Rassidakis GZ
Blood; 2007 Sep; 110(5):1621-30. PubMed ID: 17416736
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of basal JNK activity by small interfering RNAs enhances cisplatin sensitivity and decreases DNA repair in T98G glioblastoma cells.
Parra E; Gutiérrez L; Ferreira J
Oncol Rep; 2015 Jan; 33(1):413-8. PubMed ID: 25351964
[TBL] [Abstract][Full Text] [Related]
9. Distinct role of c-Jun N-terminal kinase isoforms in human neutrophil apoptosis regulated by tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor.
Kato T; Noma H; Kitagawa M; Takahashi T; Oshitani N; Kitagawa S
J Interferon Cytokine Res; 2008 Apr; 28(4):235-43. PubMed ID: 18439101
[TBL] [Abstract][Full Text] [Related]
10. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
Liu J; Minemoto Y; Lin A
Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
[TBL] [Abstract][Full Text] [Related]
11. Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding.
Kook S; Zhan X; Kaoud TS; Dalby KN; Gurevich VV; Gurevich EV
J Biol Chem; 2013 Dec; 288(52):37332-42. PubMed ID: 24257757
[TBL] [Abstract][Full Text] [Related]
12. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
[TBL] [Abstract][Full Text] [Related]
13. RACK1 mediates activation of JNK by protein kinase C [corrected].
López-Bergami P; Habelhah H; Bhoumik A; Zhang W; Wang LH; Ronai Z
Mol Cell; 2005 Aug; 19(3):309-20. PubMed ID: 16061178
[TBL] [Abstract][Full Text] [Related]
14. Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.
Bildik G; Akin N; Senbabaoglu F; Esmalian Y; Sahin GN; Urman D; Karahuseyinoglu S; Ince U; Palaoglu E; Taskiran C; Arvas M; Guzel Y; Yakin K; Oktem O
Cell Death Dis; 2018 Apr; 9(4):421. PubMed ID: 29549247
[TBL] [Abstract][Full Text] [Related]
15. Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.
Cubero FJ; Zoubek ME; Hu W; Peng J; Zhao G; Nevzorova YA; Al Masaoudi M; Bechmann LP; Boekschoten MV; Muller M; Preisinger C; Gassler N; Canbay AE; Luedde T; Davis RJ; Liedtke C; Trautwein C
Gastroenterology; 2016 Apr; 150(4):968-81. PubMed ID: 26708719
[TBL] [Abstract][Full Text] [Related]
16. JNK1 Deficient Insulin-Producing Cells Are Protected against Interleukin-1β-Induced Apoptosis Associated with Abrogated Myc Expression.
Prause M; Mayer CM; Brorsson C; Frederiksen KS; Billestrup N; Størling J; Mandrup-Poulsen T
J Diabetes Res; 2016; 2016():1312705. PubMed ID: 26962537
[TBL] [Abstract][Full Text] [Related]
17. Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo.
Kaiser RA; Liang Q; Bueno O; Huang Y; Lackey T; Klevitsky R; Hewett TE; Molkentin JD
J Biol Chem; 2005 Sep; 280(38):32602-8. PubMed ID: 16043490
[TBL] [Abstract][Full Text] [Related]
18. Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells.
Okada M; Shibuya K; Sato A; Seino S; Watanabe E; Suzuki S; Seino M; Kitanaka C
Oncol Rep; 2013 Oct; 30(4):1957-64. PubMed ID: 23912840
[TBL] [Abstract][Full Text] [Related]
19. Manipulating JNK signaling with (--)-zuonin A.
Kaoud TS; Park H; Mitra S; Yan C; Tseng CC; Shi Y; Jose J; Taliaferro JM; Lee K; Ren P; Hong J; Dalby KN
ACS Chem Biol; 2012 Nov; 7(11):1873-83. PubMed ID: 22916726
[TBL] [Abstract][Full Text] [Related]
20. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
Zhu MM; Tong JL; Xu Q; Nie F; Xu XT; Xiao SD; Ran ZH
PLoS One; 2012; 7(8):e41763. PubMed ID: 22870247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
